Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$18,000.00
May 1, 2020
For-profit organization
Market Assessment & Strategic Planning
948808
The project will conduct a market assessment to analyze potential markets, customer needs, and short/medium term opportunities. The goal is a three year Strategic Development Plan for the firm.
$122,040.00
May 1, 2020
For-profit organization
Artificial Intelligence (AI)-based system for drug profiling
948869
The firm is building an artificial intelligence-based system which would be used to computationally profile drug candidates against multiple protein kinases simultaneously. The goal is to dramatically increase the efficiency of drug target screening.
$45,820.00
Sep 1, 2019
For-profit organization
Artificial intelligence-based compound screening system for drug discovery
933368
The inaccuracy of the available computational methods limits the success rate of structure-based in silico drug screening. By taking advantage of abundant experimental data and state-of-the-art artificial intelligence technologies, we are developing a system which overcomes the weaknesses of current screening methods.